ADD/ADHD News

Recent findings suggest risk for autism and attention-deficit/hyperactivity disorder may be influenced by factors associated with prenatal antidepressant use, but not antidepressant use itself.

As the year comes to a close, Healio.com/Psychiatry revisited our most popular psychiatry coverage of 2015.

As 2015 comes to a close, Healio.com/Psychiatry took a moment to review the top stories regarding attention-deficit/hyperactivity disorder throughout the year.

Middle and high school students prescribed attention-deficit/hyperactivity disorder medication reported more peer victimization compared with ADHD students who had never received medication and adolescents without ADHD, according to research in the Journal of Pediatric Psychology.

Cross-network interactions in the salience, central executive and default mode networks were significantly lower among children with attention-deficit/hyperactivity disorder and linked to inattention symptoms, according to recent findings.

Pfizer recently announced FDA approval of its QuilliChew ER for treatment of attention-deficit/hyperactivity disorder among children aged 6 years and older, according to a press release.

Analysis of national study data show an increase in parent-reported prevalence of attention-deficit/hyperactivity disorder from 2003 to 2011, and that socioeconomic variables affect prevalence differentially between racial/ethnic groups.

Mylan recently announced the U.S. launch of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets, the generic version of Teva Pharmaceutical’s Adderall tablets.

A recent Cochrane Review indicated methylphenidate may improve teacher-reported attention-deficit/hyperactivity disorder symptoms, teacher-reported general behavior and parent-reported quality of life among youth with the disorder, however, evidence was low-quality and therefore could not confirm findings.

Results from a meta-analysis show stimulant medication led to longer sleep latency, worse sleep efficiency and shorter sleep duration among youth with attention-deficit/hyperactivity disorder.